Veru to present at the 2nd annual glp-1-based therapeutics summit

Miami, fl, april 16, 2025 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that the company will present at the 2nd annual glp-1-based therapeutics summit, taking place april 29 - may 1, 2025, in boston, massachusetts.
VERU Ratings Summary
VERU Quant Ranking